文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

霍乱患者广泛抗生素暴露与临床相关菌群变化相关

Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes.
PubMed 文献 · J Infect Dis · 2019-01-01

研究在孟加拉国845例患者中建立LC/MS法检测抗生素暴露,90例霍乱阳性者中86%粪便检出至少一种抗生素、52%检出至少两种;44例配对尿便标本中98%检出至少一种、84%检出至少两种,而仅55%自报用药。指南推荐阿奇霉素检出与霍乱弧菌抑制相关(P=.040),甲硝唑与厌氧菌减少相关(P<.001)。

要点

  • 霍乱患者实际抗生素暴露远高于自报,86%粪便检出至少一种抗生素。
  • 低成本的抗生素检测生物法阴性预测值仅10%(95%CI 6%-16%),不足以替代LC/MS。
  • 阿奇霉素检出与霍乱弧菌抑制相关(P=.040),环丙沙星未显示相关。

核心结论

  • 在类似研究环境中可能不存在真正的阴性对照组来评估抗生素暴露。

研究设计与样本

  • 基于孟加拉国药品供应商调查生成靶向LC/MS优先清单,开展配对尿便样本分析。
  • 共845例患者,其中11%(90例)霍乱弧菌阳性;44例霍乱患者有配对尿便标本。

主要发现

  • 90例霍乱阳性患者粪便中86%检出至少一种抗生素,52%检出至少两种。
  • 44例配对标本中98%检出至少一种抗生素,84%检出至少两种,但仅55%自报用药。
  • 低成本抗生素检测生物法阴性预测值为10%(95%CI 6%-16%)。
  • 粪便检出阿奇霉素与霍乱弧菌抑制相关(P=.040),环丙沙星未显示相关。
  • 非推荐抗生素甲硝唑与厌氧菌(如普雷沃菌属)减少相关(P<.001)。

关键数值与推荐

  • 霍乱阳性患者粪便至少一种抗生素检出率86%,至少两种52%。
  • 配对尿便标本至少一种抗生素检出率98%,至少两种84%。
  • 生物法阴性预测值10%(95%CI 6%-16%)。
  • 阿奇霉素检出与霍乱弧菌抑制相关P=.040;甲硝唑与厌氧菌减少相关P<.001。

临床怎么用

  • 临床或研究中应优先采用LC/MS等客观方法评估抗生素暴露,不应仅依赖自报用药。
  • 低成本生物法阴性预测值低,不适合单独用于排除抗生素暴露。
  • 需关注非推荐抗生素(如甲硝唑)对肠道厌氧菌群的潜在影响。

局限性

  • 原文未报告研究设计的具体类型、样本量细节及局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A first step to combating antimicrobial resistance in enteric pathogens is to establish an objective assessment of antibiotic exposure. Our goal was to develop and evaluate a liquid chromatography-ion trap mass spectrometry (LC/MS) method to determine antibiotic exposure in patients with cholera. METHODS: A priority list for targeted LC/MS was generated from medication-vendor surveys in Bangladesh. A study of patients with and those without cholera was conducted to collect and analyze paired urine and stool samples. RESULTS: Among 845 patients, 11% (90) were Vibrio cholerae positive; among these 90 patients, analysis of stool specimens revealed ≥1 antibiotic in 86% and ≥2 antibiotics in 52%. Among 44 patients with cholera and paired urine and stool specimens, ≥1 antibiotic was detected in 98% and ≥2 antibiotics were detected in 84%, despite 55% self-reporting medication use. Compared with LC/MS, a low-cost antimicrobial detection bioassay lacked a sufficient negative predictive value (10%; 95% confidence interval, 6%-16%). Detection of guideline-recommended antibiotics in stool specimens did (for azithromycin; P = .040) and did not (for ciprofloxacin) correlate with V. cholerae suppression. A nonrecommended antibiotic (metronidazole) was associated with decreases in anaerobes (ie, Prevotella organisms; P < .001). CONCLUSION: These findings suggest that there may be no true negative control group when attempting to account for antibiotic exposure in settings like those in this study.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Alexandrova L, Haque F, Rodriguez P, et al. Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes. J Infect Dis. 2019. PMID: 31192364. doi:10.1093/infdis/jiz299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。